Adage Capital Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,436,158
Closed -$276M 787
2016
Q4
$276M Buy
3,436,158
+1,117,832
+48% +$88.7M 0.75% 24
2016
Q3
$185M Buy
2,318,326
+1,343,200
+138% +$108M 0.51% 43
2016
Q2
$76.1M Buy
975,126
+677,746
+228% +$48.3M 0.21% 135
2016
Q1
$16.4M Sell
297,380
-472,000
-61% -$25.7M 0.04% 410
2015
Q4
$47.5M Buy
769,380
+269,600
+54% +$17M 0.12% 202
2015
Q3
$31.5M Buy
499,780
+169,700
+51% +$12.1M 0.09% 291
2015
Q2
$24.1M Buy
330,080
+197,240
+148% +$14.2M 0.06% 372
2015
Q1
$8.69M Sell
132,840
-339,400
-72% -$22.6M 0.02% 575
2014
Q4
$30.7M Buy
472,240
+92,400
+24% +$5.95M 0.08% 317
2014
Q3
$22.8M Buy
379,840
+127,700
+51% +$8.34M 0.06% 365
2014
Q2
$17.5M Sell
252,140
-440,000
-64% -$28.5M 0.05% 423
2014
Q1
$45.3M Buy
692,140
+92,700
+15% +$6.03M 0.12% 218
2013
Q4
$37.1M Sell
599,440
-125,000
-17% -$7.24M 0.1% 263
2013
Q3
$38.9M Buy
724,440
+365,100
+102% +$18.8M 0.11% 239
2013
Q2
$16.4M Buy
+359,340
New +$15.6M 0.05% 408

Other funds holding STJ

Adage Capital Partners's STJ Position: Q1 2017 in Review

Adage Capital Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,436,158 shares — an estimated $276M sold.

Adage Capital Partners first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $276M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Adage Capital Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Adage Capital Partners sold 3,436,158 St Jude Medical shares in Q1 2017, an estimated $276M.
  • Adage Capital Partners first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Adage Capital Partners's St Jude Medical position peaked at $276M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Adage Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.